Cognitive function in patients with myasthenia gravis

Abstract

The study presents the results of a complex neuropsychological examination of patients with myasthenia gravis, which revealed intellectual disorders in 36.6% of cases, i.e., violations of memory processes, decreasing short-term memory level, and rapid deterioration of attention. A study of patients with myasthenia gravis with thymoma (before thymectomy) and patients with disease duration of more than 10 years found more pronounced memory and attention disorders (р < 0.05).

Keywords

myasthenia gravis / cognitive impairment / basal forebrain cholinergic system / acetylcholine receptor / neuropsychological examination

References

[1] Санадзе А.Г. Миастения и миастенические синдромы. - 2-е изд. - М.: ГЭОТАР-Медиа, 2017. [Sanadze AG. Miasteniya i miastenicheskie sindromy. 2nd ed. Moscow: GEOTAR-Media; 2017. (In Russ.)]

[2] Миастения: диагностика и лечение / Под ред. С.В. Лобзина. - СПб.: СпецЛит, 2015. [Miasteniya i miastenicheskie sindromy. Ed by S.V. Lobzin. Saint Petersburg: SpetsLit; 2015. (In Russ.)]

[3] Косачев В.Д., Алексеева Т.М., Лобзин С.В., и др. Отдаленные результаты хирургического лечения миастении // Вестник Северо-Западного государственного медицинского университета им. И.И. Мечникова. - 2016. - Т. 8. - № 3. - С. 19-23. [Kosachev VD, Alekseeva TM, Lobzin SV, et al. Long-term results of surgical treatment of myasthenia. Herald of the Northwestern State Medical University named after I.I. Mechnikov. 2016;8(3):19-23. (In Russ.)]

[4] Косачев В.Д., Соколова М.Г. Миастения (клиническая картина, диагностика, лечение). - СПб.: Изд-во СЗГМУ им. И.И. Мечникова, 2013. [Kosachev VD, Sokolova MG. Miasteniya (klinicheskaya kartina, diagnostika, lechenie). Saint Petersburg: Izdatel’stvo SZGMU im. I.I. Mechnikova; 2013. (In Russ.)]

[5] Joshi D, Bhatia M, Gupta S, et al. Cognitive evaluation in myasthenia gravis: A P300 and neuropsychological study. Neurol Asia. 2006;(11):97-102.

[6] Yakel JL. Cholinergic receptors: functional role of nicotinic ACh receptors in brain circuits and disease. Pflugers Arch. 2013;465(4):441-450. doi: 10.1007/s00424-012-1200-1.

[7] Wonnacott S, Bermudez I, Millar NS, Tzartos SJ. Nicotinic acetylcholine receptors. Br J Pharmacol. 2018;175(11):1785-1788. doi: 10.1111/bph.14209.

[8] Kaltsatou A, Fotiou D, Tsiptsios D, Orologas A. Cognitive impairment as a central cholinergic deficit in patients with Myasthenia Gravis. BBA Clin. 2015;3:299-303. doi: 10.1016/j.bbacli.2015.04.003.

[9] Hamed S, Mohamed M, Youssef A, et al. Assessment of cognitive function in patients with myasthenia gravis. Neuroimmunol Neuroinflamm. 2014;1(3):141. doi: 10.4103/2347-8659.143671.

[10] Marra C, Marsili F, Quaranta D, Evoli A. Determinants of cognitive impairment in elderly myasthenia gravis patients. Muscle Nerve. 2009;40(6):952-959. doi: 10.1002/mus.21478.

[11] Eizaguirre MB, Aguirre F, Yastremiz C, et al. Neuropsychological performance in patients with myasthenia gravis. Medicina. 2017;77(2):117-120.

[12] Paul RH, Cohen RA, Gilchrist JM, et al. Cognitive dysfunction in individuals with myasthenia gravis. J Neurol Sci. 2000;179(1-2):59-64. doi: 10.1016/s0022-510x(00)00367-1.

[13] Mao Z, Yin J, Lu Z, Hu X. Association between myasthenia gravis and cognitive function: A systematic review and meta-analysis. Ann Indian Acad Neurol. 2015;18(2):131-137. doi: 10.4103/0972-2327.156560.

[14] Jordan B, Schweden TLK, Mehl T, et al. Cognitive fatigue in patients with myasthenia gravis. Muscle Nerve. 2017;56(3):449-457. doi: 10.1002/mus.25540.

[15] Соколова, М.Г., Лобзин С.В., Никишина О.А., и др. К вопросу о патогенезе когнитивных расстройств при мышечной дистрофии Дюшенна в клинико-лабораторном и молекулярно-генетическом исследовании // Журнал неврологии и психиатрии им. С.С. Корсакова. - 2017. - Т. 117. - № 12. - С. 78-84. [Sokolova MG, Lobzin SV, Nikishina OA, et al. Pathogenesis of cognitive disorders in patients with Duchenne muscular dystrophy. Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(12):78-84. (In Russ.)]

[16] Kurlowicz L, Wallace M. The Mini-Mental State Examination (MMSE). J Gerontol Nurs. 1999;25(5):8-9. doi: 10.3928/0098-9134-19990501-08.

[17] Cunha PJ, Nicastri S, de Andrade AG, Bolla KI. The frontal assessment battery (FAB) reveals neurocognitive dysfunction in substance-dependent individuals in distinct executive domains: Abstract reasoning, motor programming, and cognitive flexibility. Addict Behav. 2010;35(10):875-881. doi: 10.1016/j.addbeh.2010.05.005.

[18] Manos PJ. 10-Point Clock Test Screens for Cognitive Impairment in Clinic and Hospital Settings. Psychiatr Times. 1998;15(10):18-21.

[19] Вартанов А.В., Козловский С.А., Скворцова В.Б., и др. Память человека и анатомические особенности гиппокампа // Вестник Московского университета. Серия 14: Психология. - 2009. - № 4. - С. 3-16. [Vartanov AV, Kozlovskiy SA, Skvortsova VB, et al. Human memory and anatomic features of the hippocampus. Vestnik Moskovskogo universiteta. Seriya 14: Psikhologiya. 2009;(4):3-16. (In Russ.)]

[20] Ахметзянова А.И. Практикум по клинической психологии. Учебно-методическое пособие. - М.: Школьная пресса, 2013. [Akhmetzyanova AI. Praktikum po klinicheskoy psikhologii. Uchebno-metodicheskoe posobie. Moscow: Shkol’naya pressa; 2013. (In Russ.)]

[21] Малкина-Пых И.Г. Психосоматика: Справочник практического психолога. - М.: Эксмо, 2005. [Malkina-Pykh IG. Psikhosomatika: Spravochnik prakticheskogo psikhologa. Moscow: Eksmo; 2005. (In Russ.)]

RIGHTS & PERMISSIONS

Nalkin S.A., Lobzin S.V., Sokolova M.G.